Telix jumps 11.6% as US government indicates proposed medicare changes won't affect prostate cancer drug
Telix has announced its prostate cancer imaging drug Illuccix won't be negatively impacted by proposed changes to the US medicare system.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
UAU | uau update | 10/11/17 | 6 | 2.8K | |||
|
|||||||
UAU | parent company and relations | 22/10/11 | 0 | 243 | |||
|
|||||||
UAU | name change: polymetallica | 02/09/11 | 2 | 1.8K | |||
|
|||||||
UAU | uau to polymetallica (aug 29 meeting) | 31/08/11 | 1 | 588 | |||
|
|||||||
UAU | 25% uranium, 31% thorium & rare earths ... | 17/05/11 | 1 | 894 | |||
|
|||||||
UAU | uau ipo?? | 29/03/11 | 10 | 2.2K | |||
|
|||||||
UAU | uau progress | 23/03/10 | 1 | 637 | |||
|
|||||||
UAU | welcome! | 28/02/10 | 3 | 992 | |||
|
See All Discussions